Detalhe da pesquisa
1.
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis.
Ann Neurol
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38780377
2.
Prognostic value of single-subject grey matter networks in early multiple sclerosis.
Brain
; 147(1): 135-146, 2024 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37642541
3.
Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis.
Brain
; 147(4): 1331-1343, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267729
4.
Incidence and determinants of seizures in multiple sclerosis: a meta-analysis of randomised clinical trials.
J Neurol Neurosurg Psychiatry
; 2024 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383156
5.
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study.
J Neurol Neurosurg Psychiatry
; 95(2): 142-150, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37775266
6.
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
Brain
; 146(6): 2489-2501, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36515653
7.
Unusual CLIPPERS presentation with a predominant spinal cord involvement: case report and review of the literature.
Neurol Sci
; 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38499887
8.
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies.
J Neurol Neurosurg Psychiatry
; 94(4): 290-299, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36522154
9.
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs.
Mult Scler
; 29(7): 856-865, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165941
10.
Patient-reported outcome measures in drugs for neurological conditions approved by European Medicines Agency 2017-2022.
Neurol Sci
; 44(8): 2933-2937, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37145229
11.
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register.
Neurol Sci
; 44(11): 4001-4011, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311951
12.
Models of care in emergency neurology: from the Neuro Fast Track to the emergency neurologist-a position paper of the Italian Association for Emergency Neurology (ANEU).
Neurol Sci
; 44(9): 3307-3317, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386326
13.
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose.
Int J Mol Sci
; 24(10)2023 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37239872
14.
Shift of multiple sclerosis onset towards older age.
J Neurol Neurosurg Psychiatry
; 2022 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477891
15.
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180219
16.
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years.
Mult Scler
; 28(13): 2137-2141, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296189
17.
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register.
Mult Scler
; 28(14): 2243-2252, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971322
18.
Job satisfaction among physicians and nurses involved in the management of multiple sclerosis: the role of happiness and meaning at work.
Neurol Sci
; 43(3): 1903-1910, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34363548
19.
Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm.
Ann Neurol
; 88(1): 93-105, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32285956
20.
Age-related adverse events of disease-modifying treatments for multiple sclerosis: A meta-regression.
Mult Scler
; 27(9): 1391-1402, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33104449